These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Alkylated/aminated nitroimidazoles and nitroimidazole-7-chloroquinoline conjugates: Synthesis and anti-mycobacterial evaluation. Shalini ; Viljoen A; Kremer L; Kumar V Bioorg Med Chem Lett; 2018 May; 28(8):1309-1312. PubMed ID: 29551480 [TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships for analogs of the tuberculosis drug bedaquiline with the naphthalene unit replaced by bicyclic heterocycles. Sutherland HS; Tong AST; Choi PJ; Conole D; Blaser A; Franzblau SG; Cooper CB; Upton AM; Lotlikar MU; Denny WA; Palmer BD Bioorg Med Chem; 2018 May; 26(8):1797-1809. PubMed ID: 29482950 [TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships for amide-, carbamate-, and urea-linked analogues of the tuberculosis drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824). Blaser A; Palmer BD; Sutherland HS; Kmentova I; Franzblau SG; Wan B; Wang Y; Ma Z; Thompson AM; Denny WA J Med Chem; 2012 Jan; 55(1):312-26. PubMed ID: 22148391 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, reduction potentials, and antitubercular activity of ring A/B analogues of the bioreductive drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824). Thompson AM; Blaser A; Anderson RF; Shinde SS; Franzblau SG; Ma Z; Denny WA; Palmer BD J Med Chem; 2009 Feb; 52(3):637-45. PubMed ID: 19099398 [TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships of antitubercular nitroimidazoles. 2. Determinants of aerobic activity and quantitative structure-activity relationships. Kim P; Kang S; Boshoff HI; Jiricek J; Collins M; Singh R; Manjunatha UH; Niyomrattanakit P; Zhang L; Goodwin M; Dick T; Keller TH; Dowd CS; Barry CE J Med Chem; 2009 Mar; 52(5):1329-44. PubMed ID: 19209893 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitubercular activity of monocyclic nitroimidazoles: insights from econazole. Lee SH; Kim S; Yun MH; Lee YS; Cho SN; Oh T; Kim P Bioorg Med Chem Lett; 2011 Mar; 21(5):1515-8. PubMed ID: 21277200 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and anti-tuberculosis activity of N-aryl-C-nitroazoles. Walczak K; Gondela A; Suwiński J Eur J Med Chem; 2004 Oct; 39(10):849-53. PubMed ID: 15464618 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and anti-tubercular activity of 2-nitroimidazooxazines with modification at the C-7 position as PA-824 analogs. Kang YG; Park CY; Shin H; Singh R; Arora G; Yu CM; Lee IY Bioorg Med Chem Lett; 2015 Sep; 25(17):3650-3. PubMed ID: 26199118 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of bicyclic nucleosides as inhibitors of M. tuberculosis thymidylate kinase. Van Daele I; Munier-Lehmann H; Hendrickx PM; Marchal G; Chavarot P; Froeyen M; Qing L; Martins JC; Van Calenbergh S ChemMedChem; 2006 Oct; 1(10):1081-90. PubMed ID: 16921580 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and antitubercular activity of new mefloquine-oxazolidine derivatives. Gonçalves RS; Kaiser CR; Lourenço MC; de Souza MV; Wardell JL; Wardell SM; da Silva AD Eur J Med Chem; 2010 Dec; 45(12):6095-100. PubMed ID: 20932608 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and discovery of new bisadducts derived from heterocyclic aldehydes and active methylene compounds as potent antitubercular agents. Asad M; Oo CW; Kumar RS; Osman H; Ali MA Acta Pol Pharm; 2013; 70(2):221-8. PubMed ID: 23614277 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and antitubercular activity of 7-(R)- and 7-(S)-methyl-2-nitro-6-(S)-(4-(trifluoromethoxy)benzyloxy)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazines, analogues of PA-824. Li X; Manjunatha UH; Goodwin MB; Knox JE; Lipinski CA; Keller TH; Barry CE; Dowd CS Bioorg Med Chem Lett; 2008 Apr; 18(7):2256-62. PubMed ID: 18358721 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity studies of biphenyl analogues of the tuberculosis drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824). Palmer BD; Thompson AM; Sutherland HS; Blaser A; Kmentova I; Franzblau SG; Wan B; Wang Y; Ma Z; Denny WA J Med Chem; 2010 Jan; 53(1):282-94. PubMed ID: 19928920 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationships for extended side chain analogues of the antitubercular drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824). Palmer BD; Sutherland HS; Blaser A; Kmentova I; Franzblau SG; Wan B; Wang Y; Ma Z; Denny WA; Thompson AM J Med Chem; 2015 Apr; 58(7):3036-59. PubMed ID: 25781074 [TBL] [Abstract][Full Text] [Related]
18. Biarylmethoxy 2-nitroimidazooxazine antituberculosis agents: Effects of proximal ring substitution and linker reversal on metabolism and efficacy. Thompson AM; Blaser A; Palmer BD; Franzblau SG; Wan B; Wang Y; Ma Z; Denny WA Bioorg Med Chem Lett; 2015 Sep; 25(18):3804-9. PubMed ID: 26253632 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel 3-cyclohexylpropanoic acid-derived nitrogen heterocyclic compounds and their evaluation for tuberculostatic activity. Gobis K; Foks H; Bojanowski K; Augustynowicz-Kopeć E; Napiórkowska A Bioorg Med Chem; 2012 Jan; 20(1):137-44. PubMed ID: 22153872 [TBL] [Abstract][Full Text] [Related]
20. The effect of 5-substitution on the electrochemical behavior and antitubercular activity of PA-824. Bollo S; Núñez-Vergara LJ; Kang S; Zhang L; Boshoff HI; Barry CE; Squella JA; Dowd CS Bioorg Med Chem Lett; 2011 Jan; 21(2):812-7. PubMed ID: 21168331 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]